Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2, Open-Label, Biomarker-Driven Study of Allogeneic Donor-Derived CAR-NK Cells With Antigen Selection by Tissue Biopsy and/or Liquid Biopsy Profiling in Participants With Relapsed/Refractory Advanced Solid Tumors (Single-Target vs Dual-Target Strategy)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07410494
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:24.031272+00:00
Published At
2026-02-18T00:00:00+00:00
Record Updated At
2026-02-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cancer", "Breast Cancer", "Non-Small Cell Lung Cancer (NSCLC)", "Colorectal Cancer (Locally Advanced or Metastatic)", "Prostate Cancer - Recurrent", "Pancreatic Ductal Adenocarcinoma (PDAC)", "Ovarian Cancer", "Glioblastoma", "Melanoma (Skin Cancer)", "Acute Myeloid Leukemia (AML)", "Non Hodgkin Lymphoma", "Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma", "Liver Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-18"
protocolSection.identificationModule.nctId
"NCT07410494"
protocolSection.identificationModule.officialTitle
"A Phase 1/2, Open-Label, Biomarker-Driven Study of Allogeneic Donor-Derived CAR-NK Cells With Antigen Selection by Tissue Biopsy and/or Liquid Biopsy Profiling in Participants With Relapsed/Refractory Advanced Solid Tumors (Single-Target vs Dual-Target Strategy)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cancer (protocolSection.conditionsModule.conditions)
  • Breast Cancer (protocolSection.conditionsModule.conditions)
  • Non-Small Cell Lung Cancer (NSCLC) (protocolSection.conditionsModule.conditions)
  • Colorectal Cancer (Locally Advanced or Metastatic) (protocolSection.conditionsModule.conditions)
  • Prostate Cancer - Recurrent (protocolSection.conditionsModule.conditions)
  • Pancreatic Ductal Adenocarcinoma (PDAC) (protocolSection.conditionsModule.conditions)
  • Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Glioblastoma (protocolSection.conditionsModule.conditions)
  • Melanoma (Skin Cancer) (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia (AML) (protocolSection.conditionsModule.conditions)
  • Non Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma (protocolSection.conditionsModule.conditions)
  • Liver Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.